Literature DB >> 10519916

Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase.

S Gagliardi1, M Rees, C Farina.   

Abstract

Bafilomycin A1, a macrolide antibiotic isolated from the fermentation of Streptomyces spp., is a potent and selective inhibitor of vacuolar-type proton translocating ATP-ases (V-ATPases) and was used to study the physiological role of this class of enzymes. An extensive chemical effort on the unusual structure of this macrolide led to the synthesis of significantly different bafilomycin derivatives. None of the new analogues was more potent than the parent compound but provided a significant amount of information about the structural requirements for the inhibitory activity of bafilomycin A1 in particular on chicken osteoclast (cOc) ATPase. The vinylic methoxy group adjacent to a carbonyl function, the dienic system and the hydroxy group at position 7 were recognized to be essential features for bafilomycin V-ATPase-inhibitory activity. This information was utilized to design simplified novel derivatives as inhibitors of bone resorption.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519916

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  21 in total

1.  Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells.

Authors:  Kejin Zhou; Yiguang Wang; Xiaonan Huang; Katherine Luby-Phelps; Baran D Sumer; Jinming Gao
Journal:  Angew Chem Int Ed Engl       Date:  2011-04-14       Impact factor: 15.336

2.  Inhibition of intramacrophage growth of Penicillium marneffei by 4-aminoquinolines.

Authors:  D Taramelli; C Tognazioli; F Ravagnani; O Leopardi; G Giannulis; J R Boelaert
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  Biological characterization of the hygrobafilomycin antibiotic JBIR-100 and bioinformatic insights into the hygrolide family of natural products.

Authors:  Evelyn M Molloy; Jonathan I Tietz; Patricia M Blair; Douglas A Mitchell
Journal:  Bioorg Med Chem       Date:  2016-05-14       Impact factor: 3.641

4.  Enhanced efficacy of photodynamic therapy via a sequential targeting protocol.

Authors:  David Kessel; John J Reiners
Journal:  Photochem Photobiol       Date:  2014-04-01       Impact factor: 3.421

5.  Rabies virus-induced activation of mitogen-activated protein kinase and NF-kappaB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia.

Authors:  Kazuo Nakamichi; Megumi Saiki; Makoto Sawada; Mutsuyo Takayama-Ito; Yutaka Yamamuro; Kinjiro Morimoto; Ichiro Kurane
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  N-arachidonoyl glycine, another endogenous agonist of GPR55.

Authors:  Linda Console-Bram; Sandra M Ciuciu; Pingwei Zhao; Robert E Zipkin; Eugen Brailoiu; Mary E Abood
Journal:  Biochem Biophys Res Commun       Date:  2017-07-08       Impact factor: 3.575

7.  Estimating the rotation rate in the vacuolar proton-ATPase in native yeast vacuolar membranes.

Authors:  Csilla Ferencz; Pál Petrovszki; Zoltán Kóta; Elfrieda Fodor-Ayaydin; Lajos Haracska; Attila Bóta; Zoltán Varga; András Dér; Derek Marsh; Tibor Páli
Journal:  Eur Biophys J       Date:  2012-11-16       Impact factor: 1.733

8.  Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus.

Authors:  Brenda L Fredericksen; Bangdong L Wei; Jian Yao; Tianci Luo; J Victor Garcia
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Bafilomycin A1 is a potassium ionophore that impairs mitochondrial functions.

Authors:  Vera V Teplova; Anton A Tonshin; Pavel A Grigoriev; Nils-Erik L Saris; Mirja S Salkinoja-Salonen
Journal:  J Bioenerg Biomembr       Date:  2007-08       Impact factor: 2.945

10.  Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury.

Authors:  Akira Uchiyama; Jae-Sung Kim; Kazuyoshi Kon; Hartmut Jaeschke; Kenichi Ikejima; Sumio Watanabe; John J Lemasters
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.